Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (251-260 of 519) with videos related to

Pageof 52
Sort By:
Clinical & Experimental Metastasis|October 4, 2003
Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endotheliumOlga V Glinskii, Virginia H Huxley, James R Turk, et al.
Expert Review of Anticancer Therapy|May 23, 2022
Piflufolastat F-18 (<sup>18</sup>F-DCFPyL) for PSMA PET imaging in prostate cancer Andrew F Voter, Rudolf A Werner, Kenneth J Pienta, et al.
Clinical & Experimental Metastasis|June 20, 2008
CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12Yan-Xi Sun, Elisabeth A Pedersen, Yusuke Shiozawa, et al.
Clinical & Experimental Metastasis|March 29, 2002
The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokinesCarlton R Cooper, Jasmine K Bhatia, Heather J Muenchen, et al.
Molecular Imaging and Biology|December 14, 2019
Letter to the Editor re: "Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake"Rudolf A Werner, Kenneth J Pienta, Martin G Pomper, et al.
Cancer|May 13, 2006
Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostateNiklas J Mackler, Rodney L Dunn, Beth Hellerstedt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B CategoriesYafu Yin, Rudolf A Werner, Takahiro Higuchi, et al.
International Journal of Cancer|August 30, 2008
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesionsJinhui Liao, Xin Li, Amy J Koh, et al.
BJU International|March 3, 2020
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancerLiang Dong, Zhongyuan Zhang, Kimberly Smith, et al.
Urology|January 30, 2004
Prostate-specific antigen doubling time and survival in patients with advanced metastatic prostate cancerRobert D Loberg, Jeffery R Fielhauer, Brian A Pienta, et al.
Pageof 52

Showing results (251-260 of 519) with videos related to

Sort By:
Pageof 52
Clinical & Experimental Metastasis|October 4, 2003
Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endotheliumOlga V Glinskii, Virginia H Huxley, James R Turk, et al.
Expert Review of Anticancer Therapy|May 23, 2022
Piflufolastat F-18 (<sup>18</sup>F-DCFPyL) for PSMA PET imaging in prostate cancer Andrew F Voter, Rudolf A Werner, Kenneth J Pienta, et al.
Clinical & Experimental Metastasis|June 20, 2008
CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12Yan-Xi Sun, Elisabeth A Pedersen, Yusuke Shiozawa, et al.
Clinical & Experimental Metastasis|March 29, 2002
The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokinesCarlton R Cooper, Jasmine K Bhatia, Heather J Muenchen, et al.
Molecular Imaging and Biology|December 14, 2019
Letter to the Editor re: "Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake"Rudolf A Werner, Kenneth J Pienta, Martin G Pomper, et al.
Cancer|May 13, 2006
Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostateNiklas J Mackler, Rodney L Dunn, Beth Hellerstedt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B CategoriesYafu Yin, Rudolf A Werner, Takahiro Higuchi, et al.
International Journal of Cancer|August 30, 2008
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesionsJinhui Liao, Xin Li, Amy J Koh, et al.
BJU International|March 3, 2020
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancerLiang Dong, Zhongyuan Zhang, Kimberly Smith, et al.
Urology|January 30, 2004
Prostate-specific antigen doubling time and survival in patients with advanced metastatic prostate cancerRobert D Loberg, Jeffery R Fielhauer, Brian A Pienta, et al.
Pageof 52